Publications

Mayeta Clark 2015

Evidence uptake is only part of the process: Stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria

March 14, 2024

Health policy processes should be evidence-informed, transparent and timely, but these processes are often unclear to stakeholders outside the immediate…

Read More

Comparing malaria risk exposure in rural Cambodia population using GPS tracking and questionnaires

March 12, 2024

The Great Mekong Subregion has attained a major decline in malaria cases and fatalities over the last years, but residual…

Read More

Progress towards safer and more effective radical cure of Plasmodium vivax

March 4, 2024

Plasmodium vivax causes a substantial burden of disease in the Americas, the Horn of Africa, and Asia-Pacific. The parasite forms dormant…

Read More

Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe Cambodia

February 15, 2024

Background Over the last decades, the number of malaria cases has drastically reduced in Cambodia. As the overall prevalence of…

Read More

Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model

January 9, 2024

Background Malaria transmission modelling has demonstrated the potential impact of semiquantitative glucose-6-phosphate dehydrogenase (G6PD) testing and treatment with single-dose tafenoquine…

Read More

A cross-sectional study to ascertain malaria prevalence among asymptomatic travellers arriving on the Lihir Group of Islands, Papua New Guinea: implications for elimination efforts

November 29, 2023

Background The Lihir Islands of Papua New Guinea host a mining operation that has resulted in a mine-impacted zone (MIZ)…

Read More

Comparison of new computational method for spatial modelling of malaria

November 21, 2023

Geostatistical analysis of health data is increasingly used to model spatial variation in malaria prevalence, burden, and other metrics. Traditional…

Read More

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial

November 15, 2023

Background In areas co-endemic for Plasmodium vivax and Plasmodium falciparum there is an increased risk of P vivax parasitaemia following P falciparum malaria. Radical cure is currently only…

Read More

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

October 10, 2023

Background Imperfect adherence is a major barrier to effective primaquine radical cure of Plasmodium vivax. This study investigated the effect of…

Read More

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

September 22, 2023

Primaquine is used to eliminate Plasmodium vivax hypnozoites, but its optimal dosing regimen remains unclear. We undertook a systematic review and individual…

Read More

1 2 3 27